Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Integrated Industries Ltd, a promising small-cap stock trading below ₹50, is set to capture market attention on Monday following significant corporate developments that could impact its valuation and investor interest.
Expert analyst Sumeet Bagadia reveals his three must-buy stock recommendations for Monday trading. Discover which stocks could deliver strong returns in current market conditions.
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Bombay Stock Exchange shares surge as regulatory concerns fade. Discover key factors driving this rally and what investors should watch in coming months.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Discover how Deep Diamond India's shares hit upper circuit despite broader market selloff. This micro-cap stock under ₹10 continues its winning streak, catching investor attention.
Foreign institutional investors are aggressively increasing their stake in a remarkable penny stock that has delivered staggering 2,300% returns over five years. Discover why this multibagger is capturing smart money attention in Q2 FY26.
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Discover Marketsmith India's latest stock recommendations with detailed technical analysis and entry strategies for potential high-growth opportunities in current market conditions.
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Indian stock market witnessed significant movement on October 23 with Vodafone Idea, Bharat Forge, and Infosys emerging as top performers. Get complete analysis of gainers and losers.
A budget-friendly logistics stock trading below ₹50 has witnessed significant gains after the company shared crucial updates with stock exchanges. Discover why investors are rushing to buy this penny stock and what it means for your portfolio.
Discover why this small-cap stock is outperforming the market with a nearly 6% surge. Get expert insights on the rally and future prospects for savvy investors.
A small-cap company's shares surge dramatically following corporate actions including stock split and bonus issue, creating massive investor excitement in Indian markets.
Expert stock picks from Mehta Equities reveal promising short-term opportunities in Bharti Airtel, Motilal Oswal, and PayTM. Discover key technical levels and investment strategies.
Indian markets poised for optimistic opening as GIFT Nifty trends upward. Infosys, HCL Tech, Maruti, and Power Grid in focus amid falling gold prices and mixed global signals. Get expert analysis on today's trading strategy.
Expert analyst Vaishali Parekh shares her top three stock recommendations for today's trading session. Discover which stocks are poised for growth and why you should consider adding them to your portfolio immediately.
Marketsmith India reveals critical market analysis and stock recommendations as Indian indices approach decisive breakout zones. Discover which sectors and stocks show strongest potential.
Get ready for market action! Trade Brains reveals top stock recommendations for Nifty and Sensex. Discover which stocks could deliver strong returns in today's volatile session.
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Plant-based protein pioneer Beyond Meat experiences explosive 110% surge as retail investors trigger meme stock mania on Wall Street. Discover the driving forces behind this dramatic rally.
US stocks traded flat as investors await Tesla's crucial earnings report while Netflix shares tumble 8% following mixed quarterly results. Key market insights and analysis.
A landmark India-US trade agreement could slash tariffs dramatically, creating massive opportunities in IT, pharmaceuticals, and manufacturing sectors. Discover which stocks could benefit most.
Gold experiences sudden flash crash while stock markets show signs of fatigue. Get expert insights on market trends, Federal Reserve impact, and investment strategies for Indian investors.
Trading activities at NSE and BSE remain suspended today for Bali Pratipada celebrations. Markets to resume normal operations tomorrow. Plan your investment moves accordingly.
Indian stock exchanges remain closed today in observance of Bali Pratipada festival. Normal trading activities will resume on Thursday. Get complete details about market holidays and trading schedule.